Trial Profile
A Phase 1 Randomised, Open Label, Dose-Escalating Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Intravenous CT-P27 with or without Oseltamivir in Healthy Subjects
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 31 May 2017
Price :
$35
*
At a glance
- Drugs CT P27 (Primary) ; Oseltamivir
- Indications Influenza virus infections
- Focus Adverse reactions
- Sponsors Celltrion
- 07 Sep 2016 New trial record